Ana Class
Gerontology · Orlando, FLNPI 1861923179
Payments from drug & device makers
Across 102 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$351
- AstraZeneca$154
- Pfizer$148
- Lilly USA, LLC$139
- Amarin Pharma, Inc.$133
- GSK$118
- plus $551 from 14 others
What the payments were for
- Food & beverage$1,595100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $351 |
| AstraZeneca | 10 | $154 |
| Pfizer | 8 | $148 |
| Lilly USA, LLC | 11 | $139 |
| Amarin Pharma, Inc. | 7 | $133 |
| GSK | 13 | $118 |
| AbbVie | 4 | $91 |
| Boehringer Ingelheim | 5 | $76 |
| Amgen | 4 | $57 |
| Johnson & Johnson | 3 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $44 |
| Merck | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Abbott | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
| Bayer | 1 | $12 |
How this compares
$1,595 in reported general payments places this provider in the 70th percentile of 714 gerontology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 23 | $31,988 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $2,180 |
| Omega-3 Acid Ethyl Esters | 11 | $956 |
| Atorvastatin Calcium | 69 | $657 |
| Fluticasone Propionate | 66 | $628 |
| Levothyroxine Sodium | 43 | $519 |
| Omeprazole | 34 | $437 |
| Tamsulosin Hcl | 21 | $395 |
| Rosuvastatin Calcium | 23 | $343 |
| Gabapentin | 33 | $341 |
| Famotidine | 29 | $338 |
| Memantine Hcl | 18 | $317 |
| Pantoprazole Sodium | 30 | $302 |
| Losartan Potassium | 26 | $291 |
| Metformin Hcl | 33 | $241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $31,98823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 714 gerontology providers in Florida.
Other gerontology in Orlando
- Boni MayOrlando$22K
- Daniel Prieto RomeroOrlando$9K
- Michelle ChanceOrlando$7K
- Jing LiuOrlando$6K
- Noureen DhananiThe Villages$276K
- Flavius NascimentoCoral Springs$226K
- Michelle HartogWinter Park$90K
- Alejandra Rosales-CohenOrange City$88K
- Jennifer PacilettiAtlantis$66K
- Tatiana ClarkBradenton$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.